Parkinsonism & Related Disorders

Title Publication Date Language Citations
Quantification of brain-derived extracellular vesicles in plasma as a biomarker to diagnose Parkinson's and related diseases2019/04/01English68
Nonmotor symptoms of Parkinson's disease: Prevalence and awareness of patients and families2008/05/01English68
Age-, gender-, and socioeconomic status-specific incidence of Parkinson's disease and parkinsonism in North East Scotland: The PINE study2013/05/01English68
Structural and functional neuroimaging in patients with Parkinson's disease and visual hallucinations: A critical review2015/07/01English68
Health related quality of life in early Parkinson's disease: Impact of motor and non-motor symptoms, results from Chinese levodopa exposed cohort2009/12/01English67
Prevalence of cervical dystonia and spasmodic torticollis in the United States general population2007/10/01English67
Prevalence and associated features of self-reported freezing of gait in Parkinson disease: The DEEP FOG study2015/06/01English67
Swallowing and deep brain stimulation in Parkinson's disease: A systematic review2013/09/01English66
A Swedish family with de novo α-synuclein A53T mutation: Evidence for early cortical dysfunction2009/11/01English66
Hospitalization in Parkinson disease: A survey of National Parkinson Foundation Centers2011/07/01English66
Non-motor symptoms burden, mood, and gait problems are the most significant factors contributing to a poor quality of life in non-demented Parkinson's disease patients: Results from the COPPADIS Study Cohort2019/09/01English66
Lower urinary tract symptoms in Parkinson's disease: Prevalence, aetiology and management2017/02/01English66
Loss of benefit in VIM thalamic deep brain stimulation (DBS) for essential tremor (ET): How prevalent is it?2013/07/01English66
Dietary fats, cholesterol and iron as risk factors for Parkinson's disease2009/01/01English66
Prevalence and features of peripheral neuropathy in Parkinson's disease patients under different therapeutic regimens2014/01/01English65
CSF tau and tau/Aβ42 predict cognitive decline in Parkinson's disease2015/03/01English65
Movement disorders induced by deep brain stimulation2016/04/01English65
Single-blind clinical trial of psychotherapy for treatment of psychogenic movement disorders2006/04/01English65
Cortical and amygdalar Lewy body burden in Parkinson's disease patients with visual hallucinations2006/05/01English65
Montreal Cognitive Assessment for the screening and prediction of cognitive decline in early Parkinson's disease2014/11/01English65
Anxiety and motor fluctuations in Parkinson's disease: A cross-sectional observational study2012/12/01English65
Assessing mobility at home in people with early Parkinson’s disease using an instrumented Timed Up and Go test2011/05/01English65
Incidence and mortality trends of aspiration pneumonia in Parkinson's disease in the United States, 1979–20102015/09/01English65
Efficacy and safety of deferiprone for the treatment of pantothenate kinase-associated neurodegeneration (PKAN) and neurodegeneration with brain iron accumulation (NBIA): Results from a four years follow-up2014/06/01English65
Risks of intracranial hemorrhage in patients with Parkinson's disease receiving deep brain stimulation and ablation2010/02/01English65
Long-term response to continuous duodenal infusion of levodopa/carbidopa gel in patients with advanced Parkinson disease: The Barcelona registry2015/08/01English64
Defining the Parkinson's disease phenotype: initial symptoms and baseline characteristics in a clinical cohort2005/05/01English64
Intact limbic-prefrontal connections and reduced amygdala volumes in Parkinson's disease with mild depressive symptoms2012/08/01English64
The effects of vibrotactile biofeedback training on trunk sway in Parkinson's disease patients2012/11/01English64
CSF α-synuclein and UCH-L1 levels in Parkinson's disease and atypical parkinsonian disorders2014/04/01English64